## Clinical Context: Guillain-Barré Syndrome with Hyperkalemia This patient presents with classic Guillain-Barré syndrome (GBS)—acute demyelinating polyradiculoneuropathy. The complication here is **severe hyperkalemia** (K+ = 6.8 mEq/L), which is a known risk in GBS due to muscle breakdown and rhabdomyolysis. ## Mechanism of Hyperkalemia-Induced Cardiac Changes **Key Point:** Hyperkalemia causes peaked T waves and prolonged QT by altering the **repolarization phase** of the cardiac action potential. ### Normal Repolarization During phase 3 of the cardiac action potential, **K+ efflux** through voltage-gated K+ channels (primarily IK) restores the negative membrane potential. This outward K+ current is the dominant repolarizing force. ### Effect of Hyperkalemia 1. Elevated extracellular K+ reduces the K+ concentration gradient (inside-to-outside) 2. By the Nernst equation, the K+ equilibrium potential becomes **less negative** (moves from −90 mV toward 0 mV) 3. The driving force for K+ efflux **decreases** 4. Repolarization slows → **prolonged QT interval** 5. Early repolarization (phase 1–2) becomes exaggerated → **peaked T waves** **High-Yield:** The peaked T wave is the **earliest ECG sign of hyperkalemia** and reflects altered phase 2–3 repolarization kinetics. ## Why This Is Not the Other Options | Phase | Ion Channel | Effect of Hyperkalemia | ECG Finding | |-------|-------------|----------------------|-------------| | **Phase 0 (Depolarization)** | Na+ influx ↓ | Slowed QRS, prolonged PR | NOT peaked T | | **Phase 2 (Plateau)** | Ca2+ influx | Shortened plateau | NOT peaked T | | **Phase 3 (Repolarization)** | K+ efflux ↓ | **Slowed repolarization** | **Peaked T + prolonged QT** | | **Na+/K+ ATPase block** | Loss of gradient | Depolarization, arrhythmia | NOT selective peaked T | **Clinical Pearl:** Peaked T waves appear at K+ ~5.5–6.5 mEq/L; at K+ >7, you see loss of P wave, widened QRS, and sine-wave pattern—signs of imminent cardiac arrest. ## Management Tie-In **Key Point:** Acute hyperkalemia treatment targets: 1. **Shift K+ intracellularly:** insulin + glucose, β~2~-agonists (albuterol), sodium bicarbonate 2. **Remove K+ from body:** diuretics, cation exchange resins, dialysis 3. **Stabilize myocardium:** calcium gluconate (does NOT lower K+, but antagonizes membrane effects) [cite:Guyton & Hall Ch 5]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.